Last reviewed: June 2, 2026
Last updated: June 2, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Hair loss during GLP-1 medication use is a reported concern, though it is not a direct drug effect. Rather, rapid weight loss, reduced caloric intake, micronutrient deficiencies, and metabolic stress can trigger telogen effluvium—a temporary hair shedding condition. Clinical data suggests 15-30% of patients on intensive weight-loss therapies experience some degree of hair thinning within 3-6 months.
Understanding your individual nutritional status and genetic predispositions in nutrient metabolism can help you work with your provider to implement targeted prevention strategies. PlexusDx's precision-wellness approach integrates biomarker assessment and genetic insights to support a more informed conversation about hair health, nutritional supplementation, and GLP-1 medication management.
Why Hair Loss Occurs During Rapid Weight Loss and GLP-1 Use
Hair growth requires stable protein intake, micronutrients (iron, zinc, biotin, vitamin D), and steady metabolic conditions. Rapid weight loss and reduced food intake can create a nutrient deficit, shifting hair follicles from the active growth phase (anagen) into the shedding phase (telogen). This process, called telogen effluvium, typically emerges 2-3 months after metabolic or nutritional stress begins.
GLP-1 medications themselves do not directly cause hair loss. However, they reduce appetite and food intake, which can lower overall protein and micronutrient consumption. Additionally, the metabolic shift from higher insulin levels to lower insulin sensitivity may affect hair follicle cycling and nutrient distribution patterns in the scalp.
Critical Micronutrients and Biomarker Assessment for Hair Preservation
Before starting GLP-1 treatment, baseline biomarker testing can reveal pre-existing nutritional deficiencies or genetic predispositions in nutrient metabolism. Key biomarkers include serum iron, ferritin, vitamin D, zinc, B12, and folate levels. Understanding your baseline status enables your provider to recommend preventive supplementation tailored to your individual needs, rather than generic dosing.
| Nutrient |
Role in Hair Health |
Suggested Baseline Test |
Key Threshold |
| Iron (Ferritin) |
Oxygen transport to follicles; essential for anagen phase |
Serum ferritin, iron panel |
Ferritin >30 ng/mL optimal |
| Zinc |
Protein synthesis; immune function; follicle stability |
Serum zinc |
Zinc >70 mcg/dL target |
| Vitamin D |
Immune regulation; hair cycle modulation |
25-hydroxyvitamin D |
30-50 ng/mL recommended |
| Protein/Amino Acids |
Structural foundation for keratin; follicle cell growth |
Serum albumin; total protein |
Albumin >3.5 g/dL target |
Nutritional Strategies to Support Hair Health During GLP-1 Treatment
Maintain consistent protein intake (0.8-1.0 g per pound of body weight) despite reduced appetite. Protein provides amino acids necessary for keratin synthesis. Incorporate high-bioavailability sources such as eggs, Greek yogurt, lean fish, and collagen peptides. Small, frequent meals help achieve protein targets without overwhelming appetite suppression.
Supplement targeted micronutrients based on your baseline biomarker results. Iron supplementation may be necessary if ferritin drops below 20 ng/mL; zinc and biotin support follicle resilience; vitamin D regulates immune-related hair shedding. Work with your provider to avoid excessive supplementation, which can cause gastrointestinal side effects on GLP-1 therapy. Additionally, consider collagen or keratin-boosting supplements as adjunctive support.
Evaluating Your Individual Risk and When to Involve Your Healthcare Provider
Hair loss risk increases if you have a pre-existing nutritional deficiency, history of autoimmune hair conditions, or rapid weight loss exceeding 2-3 pounds per week. Your provider should screen for these factors before initiating GLP-1 therapy. Women, individuals with a family history of androgenetic alopecia, and those on certain medications (corticosteroids, beta-blockers) may experience heightened sensitivity to metabolic stress on hair.
If you notice increased hair shedding (more than 100-150 strands daily), alert your provider promptly. They can assess whether nutritional supplementation, reduced weight-loss pace, or medication adjustment is warranted. In most cases, telogen effluvium resolves within 3-6 months of nutritional repletion and metabolic stabilization, though recovery may extend longer in severe cases.
How PlexusDx Supports a More Personalized Approach
PlexusDx's Precision Peptide Genetic Test may help provide context for individual differences in nutrient metabolism and absorption. Genetic variants in nutrient transporter genes and metabolic pathways can influence how efficiently your body utilizes iron, vitamin D, and other micronutrients critical to hair health. This insight, interpreted with a qualified healthcare provider, can support more targeted supplementation strategies.
The genetic test does not predict whether you will experience hair loss on GLP-1 therapy—rather, it reveals predispositions in nutrient metabolism that may inform preventive conversations with your provider. For example, variants affecting vitamin D metabolism may suggest prioritizing baseline vitamin D testing and potential supplementation before GLP-1 initiation.
Combining your biomarker assessment with genetic insights creates a more complete picture for your provider. This personalized data can support discussion about protective supplementation timing, dosing, and monitoring intervals—helping optimize both weight-loss efficacy and hair health outcomes during GLP-1 treatment.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Tirzepatide Overdose: Safety, Risks & Clinical Management
Semaglutide for Menopause Weight Loss: Clinical Evidence